SciELO - Scientific Electronic Library Online

 
vol.30 número6Real-life effectiveness and safety of fixed amlodipine/irbesartan in hypertension management in Latin America: the PARCERIA study índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Em processo de indexaçãoCitado por Google
  • Não possue artigos similaresSimilares em SciELO
  • Em processo de indexaçãoSimilares em Google

Compartilhar


Revista Colombiana de Cardiología

versão impressa ISSN 0120-5633

Resumo

GARCIA-PENA, Ángel A. et al. Colombian Cholesterol Roadmap. National roundtable on cholesterol in Colombia. Call to action. Rev. Colomb. Cardiol. [online]. 2023, vol.30, n.6, pp.316-321.  Epub 04-Jan-2024. ISSN 0120-5633.  https://doi.org/10.24875/rccar.m23000222.

Atherosclerotic cardiovascular diseases (including myocardial infarction, stroke, and peripheral arterial disease) continue to be a leading cause of premature death, disability, and healthcare expenditures worldwide. Therefore, preventing the vascular accumulation of atherogenic cholesterol-containing lipoproteins is crucial in averting major cardiovascular events. The Colombian Cholesterol Roadmap update is the outcome of a meeting held during the 2023 National Cardiology Congress, with the support of the World Heart Federation and a panel of clinical and thematic experts, along with representatives from various institutions involved in the management of dyslipidaemias in Colombia. The present update of this Cholesterol Roadmap provides a conceptual framework to describe the findings and achievements derived from working groups focused on identifying barriers that hinder the appropriate treatment of hypercholesterolemia in Colombia. It also outlines proposed actions adjusted to the local context, aiming to develop national policies and approaches within our healthcare systems. Furthermore, it reaffirms the commitment to intersectoral collaboration to achieve the cardiovascular health goals set for the year 2030.

Palavras-chave : Dyslipidemia; Hypercholesterolemia; Atherosclerotic cardiovascular diseases; Health goals; World Heart Federation.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )